Frozen and Liquid Premix Systems

Patient in a hospital bed talking to a healthcare professional, with an infusion pump in the background


Clinical guidelines call for increased safety and simplicity in medication delivery. Market data demonstrate delivery which provides convenience can build clinician preference. BioPharma Solutions provides delivery systems designed to improve compliance with safety guidelines and to reduce the potential for:

  • Medication errors
  • Medication contamination

Baxter’s Frozen and Liquid Premix GALAXY Systems provide a unique menu of packaging options to meet critical patient needs while growing your product's market advantage.

Whether your product is new to market or firmly established, Baxter’s portfolio of parenteral delivery systems can create advantages even in crowded drug classes—and build long-lasting market differentiation.

Clinician interacting with a patient


  • A history of innovation as the first company to introduce premixed drugs in IV containers and the first company to form alliances with pharmaceutical companies to package their drugs in IV containers
  • Proven expertise with more than one billion sterile units manufactured per year
  • An established clinician user base, providing a valuable distribution channel to help expedite new product introductions, along with sales and marketing support services
  • Full-service capabilities from development work through commercialization
  • Research shows that clinicians prefer packaging that saves unnecessary steps and increases time for patient care. Today, they also need solutions that help them comply with strict standards for medication admixture.

Baxter’s delivery systems eliminate many of the complex procedures required for traditional IV admixture and compounding:


Smiling nurse at the bedside of smiling pediatric patient holding a teddy bear.

Baxter’s convenient, ready-to-use Frozen Premix Systems (GALAXY* non-PVC container) move patient care forward, while also maximizing your molecule’s versatility and value by:

  • Liquid Premix System
  • Increasing loyalty through safer preparation, simplified training, and reduced waste
  • Creating a reliable, secondary delivery option for incremental value
  • The potential for enhancing sales and market share wherever you are in your product’s lifecycle
Nurse is walking down hallway, guiding pole holding infusion pumps and a Baxter premixed solution bag; pediatric patient receiving the infusion walking next to nurse.

Baxter’s Frozen Premix Systems are specifically designed for unstable molecules — yet another opportunity we have to help you create new paths for growth:

  • Proprietary aseptic filling for unstable and heat-sensitive drugs
  • Flexible, 100% non-PVC material
  • Available in 50 mL, 100 mL, and 200 mL sizes
  • Proven frozen ordering and distribution channel
  • No overwrap or over pouch requirement
  • Separable and low fragility at frozen temperatures
  • Rigid administration port for safe and easy spiking
  • Multi-color printing on inner nylon layer and bar coding on individual container
  • Only available for the US Market


A mother holding her premature infant to her chest and looking fondly down at the baby, with Infusion pumps in the background.

New drug preparation standards are driving greater interest in ready-to-administer systems. By offering your product in a convenient, ready-to-use premix package, you can:

  • Increase customer loyalty through safer preparation, simplified training, and reduced waste
  • Create a competitive edge at any point in your product's lifecycle
Clinician standing next to patient in bed, inspecting bag of medication

Baxter's Liquid Premix systems are preferred for safer medication delivery for liquid-stable molecules:

  • Store at room temperature or refrigerated conditions
  • Available in 50 mL, 100 mL, 150 mL, 200 mL, and 250 mL sizes
  • State-of-the-art bar code